{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:08:58Z","timestamp":1778458138745,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":117,"publisher":"Springer US","isbn-type":[{"value":"9781071652633","type":"print"},{"value":"9781071652640","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5264-0_10","type":"book-chapter","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:40:13Z","timestamp":1778456413000},"page":"191-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of EBV Infection and Epigenetic Factors in Radioresistance of Colorectal Cancer"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3430-9297","authenticated-orcid":false,"given":"Yuanqi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-4499","authenticated-orcid":false,"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"1","key":"10_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.109","volume":"47","author":"YH Ko","year":"2015","unstructured":"Ko YH (2015) EBV and human cancer. Exp Mol Med 47(1):e130. https:\/\/doi.org\/10.1038\/emm.2014.109","journal-title":"Exp Mol Med"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/Fonc.2018.00265","volume":"8","author":"A El-Sharkawy","year":"2018","unstructured":"El-Sharkawy A, Al Zaidan L, Malki A (2018) Epstein-Barr virus-associated malignancies: roles of viral oncoproteins in carcinogenesis. Front Oncol 8:265. https:\/\/doi.org\/10.3389\/Fonc.2018.00265","journal-title":"Front Oncol"},{"issue":"4","key":"10_CR3","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1007\/s13277-014-2941-6","volume":"36","author":"N Gaur","year":"2015","unstructured":"Gaur N, Gandhi J, Robertson ES, Verma SC, Kaul R (2015) Epstein-Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis. Tumour Biol 36(4):3051\u20133060. https:\/\/doi.org\/10.1007\/s13277-014-2941-6","journal-title":"Tumour Biol"},{"issue":"11","key":"10_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8111824","volume":"8","author":"Q Rosemarie","year":"2020","unstructured":"Rosemarie Q, Sugden B (2020) Epstein-Barr virus: how its lytic phase contributes to oncogenesis. Microorganisms 8(11):1824. https:\/\/doi.org\/10.3390\/microorganisms8111824","journal-title":"Microorganisms"},{"issue":"9","key":"10_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044810","volume":"7","author":"CY Fang","year":"2012","unstructured":"Fang CY, Huang SY, Wu CC, Hsu HY, Chou SP, Tsai CH, Chang Y, Takada K, Chen JY (2012) The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells. PLoS One 7(9):e44810. https:\/\/doi.org\/10.1371\/journal.pone.0044810","journal-title":"PLoS One"},{"issue":"1","key":"10_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51(1):27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"issue":"1","key":"10_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12876-020-01395-9","volume":"20","author":"WJ Xu","year":"2020","unstructured":"Xu WJ, Jiang XY, Chen JJ, Mao QQ, Zhao XG, Sun X, Zhong L, Rong L (2020) Chronic active Epstein-Barr virus infection involving gastrointestinal tract mimicking inflammatory bowel disease. BMC Gastroenterol 20(1):257. https:\/\/doi.org\/10.1186\/s12876-020-01395-9","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13045-020-00985-0","volume":"13","author":"G Tan","year":"2020","unstructured":"Tan G, Huang CY, Chen JY, Zhi FC (2020) HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1\/2 pathway. J Hematol Oncol 13(1):149. https:\/\/doi.org\/10.1186\/s13045-020-00985-0","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10_CR9","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/cas.13584","volume":"109","author":"WL Ma","year":"2018","unstructured":"Ma WL, Feng L, Zhang SS, Zhang HJ, Zhang X, Qi XK, Zhang YC, Feng QS, Xiang T, Zeng YX (2018) Induction of chemokine (C-C motif) ligand 5 by Epstein-Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma. Cancer Sci 109(5):1710\u20131722. https:\/\/doi.org\/10.1111\/cas.13584","journal-title":"Cancer Sci"},{"key":"10_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2023.199236","volume":"338","author":"R Santarelli","year":"2023","unstructured":"Santarelli R, Evangelista L, Pompili C, Lo Presti S, Rossi A, Arena A, Gaeta A, Gonnella R, Gilardini Montani MS, Cirone M (2023) EBV infection of primary colonic epithelial cells causes inflammation, DDR and autophagy dysregulation, effects that may predispose to IBD and carcinogenesis. Virus Res 338:199236. https:\/\/doi.org\/10.1016\/j.virusres.2023.199236","journal-title":"Virus Res"},{"issue":"12","key":"10_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/13543784.2017.1389895","volume":"26","author":"I Brandsma","year":"2017","unstructured":"Brandsma I, Fleuren EDG, Williamsona CT, Lord CJ (2017) Directing the use of DDR kinase inhibitors in cancer treatment. Expert Opin Investig Drugs 26(12):1341\u20131355. https:\/\/doi.org\/10.1080\/13543784.2017.1389895","journal-title":"Expert Opin Investig Drugs"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"S875","DOI":"10.21037\/tcr.2017.06.02","volume":"6","author":"JA Nickoloff","year":"2017","unstructured":"Nickoloff JA, Boss MK, Allen CP, LaRue SM (2017) Translational research in radiation-induced DNA damage signaling and repair. Transl Cancer Res 6:S875\u2013S891. https:\/\/doi.org\/10.21037\/tcr.2017.06.02","journal-title":"Transl Cancer Res"},{"issue":"14","key":"10_CR13","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.3390\/Cancers15143642","volume":"15","author":"S Dilmac","year":"2023","unstructured":"Dilmac S, Ozpolat B (2023) Mechanisms of PARP-inhibitor-resistance in BRCA-mutated breast cancer and new therapeutic approaches. Cancer 15(14):3642. https:\/\/doi.org\/10.3390\/Cancers15143642","journal-title":"Cancer"},{"issue":"1","key":"10_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12935-023-02961-3","volume":"23","author":"S Okabe","year":"2023","unstructured":"Okabe S, Tanaka Y, Moriyama M, Gotoh A (2023) WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment. Cancer Cell Int 23(1):128. https:\/\/doi.org\/10.1186\/s12935-023-02961-3","journal-title":"Cancer Cell Int"},{"issue":"7","key":"10_CR15","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3390\/pharmaceutics15071926","volume":"15","author":"H Obata","year":"2023","unstructured":"Obata H, Ogawa M, Zalutsky MR (2023) DNA repair inhibitors: potential targets and partners for targeted radionuclide therapy. Pharmaceutics 15(7):1926. https:\/\/doi.org\/10.3390\/pharmaceutics15071926","journal-title":"Pharmaceutics"},{"key":"10_CR16","doi-asserted-by":"publisher","unstructured":"Tang Q, Wang X, Wang HX, Zhong L, Zou DL (2023) Advances in ATM, ATR, WEE1, and CHK1\/2 inhibitors in the treatment of PARP inhibitor-resistant ovarian cancer. Cancer Biol Med 20(12). https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0260","DOI":"10.20892\/j.issn.2095-3941.2023.0260"},{"issue":"3","key":"10_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/gcc.22231","volume":"54","author":"R Amirkhah","year":"2015","unstructured":"Amirkhah R, Schmitz U, Linnebacher M, Wolkenhauer O, Farazmand A (2015) MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression. Genes Chromosomes Cancer 54(3):129\u2013141. https:\/\/doi.org\/10.1002\/gcc.22231","journal-title":"Genes Chromosomes Cancer"},{"issue":"Pt C","key":"10_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.semcdb.2023.01.009","volume":"154","author":"B Chatterjee","year":"2024","unstructured":"Chatterjee B, Sarkar M, Bose S, Alam MT, Chaudhary AA, Dixit AK, Tripathi PP, Srivastava AK (2024) MicroRNAs: key modulators of inflammation-associated diseases. Semin Cell Dev Biol 154(Pt C):364\u2013373. https:\/\/doi.org\/10.1016\/j.semcdb.2023.01.009","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41418-019-0349-y","volume":"27","author":"LL Lv","year":"2020","unstructured":"Lv LL, Feng Y, Wu M, Wang B, Li ZL, Zhong X, Wu WJ, Chen J, Ni HF, Tang TT, Tang RN, Lan HY, Liu BC (2020) Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ 27(1):210\u2013226. https:\/\/doi.org\/10.1038\/s41418-019-0349-y","journal-title":"Cell Death Differ"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.omtn.2020.04.002","volume":"20","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty C, Sharma AR, Sharma G, Lee SS (2020) The interplay among miRNAs, major cytokines, and cancer-related inflammation. Mol Ther-Nucl Acids 20:606\u2013620. https:\/\/doi.org\/10.1016\/j.omtn.2020.04.002","journal-title":"Mol Ther-Nucl Acids"},{"issue":"4","key":"10_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3892\/mco.2018.1578","volume":"8","author":"QB Wu","year":"2018","unstructured":"Wu QB, Sheng X, Zhang N, Yang MW, Wang F (2018) Role of microRNAs in the resistance of colorectal cancer to chemoradiotherapy. Mol Clin Oncol 8(4):523\u2013527. https:\/\/doi.org\/10.3892\/mco.2018.1578","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"10_CR22","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.18632\/oncotarget.13659","volume":"8","author":"YQ Zhu","year":"2017","unstructured":"Zhu YQ, Peng QL, Lin YX, Zou L, Shen PP, Chen FF, Min M, Shen L, Chen JJ, Shen BR (2017) Identification of biomarker microRNAs for predicting the response colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network. Oncotarget 8(2):2233\u20132248. https:\/\/doi.org\/10.18632\/oncotarget.13659","journal-title":"Oncotarget"},{"issue":"4","key":"10_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093917","volume":"9","author":"YQ Zhang","year":"2014","unstructured":"Zhang YQ, Zheng L, Huang J, Gao F, Lin XS, He L, Li D, Li ZJ, Ding Y, Chen LH (2014) MiR-124 radiosensitizes human colorectal cancer cells by targeting PRRX1. PLoS One 9(4):e93917. https:\/\/doi.org\/10.1371\/journal.pone.0093917","journal-title":"PLoS One"},{"issue":"2","key":"10_CR24","first-page":"545","volume":"5","author":"XD Yang","year":"2015","unstructured":"Yang XD, Xu XH, Zhang SY, Wu Y, Xing CG, Ru G, Xu HT, Cao JP (2015) Role of miR-100 in the radioresistance of colorectal cancer cells. Am J Cancer Res 5(2):545\u2013559","journal-title":"Am J Cancer Res"},{"issue":"18","key":"10_CR25","doi-asserted-by":"publisher","first-page":"15984","DOI":"10.18632\/oncotarget.3762","volume":"6","author":"WH Ma","year":"2015","unstructured":"Ma WH, Yu J, Qi XL, Liang L, Zhang Y, Ding Y, Lin XS, Li GX, Ding YQ (2015) Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb. Oncotarget 6(18):15984\u201315994. https:\/\/doi.org\/10.18632\/oncotarget.3762","journal-title":"Oncotarget"},{"issue":"2","key":"10_CR26","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3892\/ijo.2014.2745","volume":"46","author":"Y Sun","year":"2015","unstructured":"Sun Y, Xing X, Liu Q, Wang Z, Xin YH, Zhang P, Hu CS, Liu Y (2015) Hypoxia-induced autophagy reduces radiosensitivity by the HIF-1\u03b1\/miR-210\/Bcl-2 pathway in colon cancer cells. Int J Oncol 46(2):750\u2013756. https:\/\/doi.org\/10.3892\/ijo.2014.2745","journal-title":"Int J Oncol"},{"issue":"11","key":"10_CR27","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s11604-017-0679-y","volume":"35","author":"HM Khoshinani","year":"2017","unstructured":"Khoshinani HM, Afshar S, Pashaki AS, Mahdavinezhad A, Nikzad S, Najafi R, Amini R, Gholami MH, Khoshghadam A, Saidijam M (2017) Involvement of miR-155\/FOXO3a and miR-222\/PTEN in acquired radioresistance of colorectal cancer cell line. Jpn J Radiol 35(11):664\u2013672. https:\/\/doi.org\/10.1007\/s11604-017-0679-y","journal-title":"Jpn J Radiol"},{"issue":"1","key":"10_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12957-021-02234-1","volume":"19","author":"C Gao","year":"2021","unstructured":"Gao C, Zhang Y, Tian Y, Han C, Wang L, Ding B, Tian H, Zhou C, Ju Y, Peng A, Yu Q (2021) Circ_0055625 knockdown inhibits tumorigenesis and improves radiosensitivity by regulating miR-338-3p\/MSI1 axis in colon cancer. World J Surg Oncol 19(1):131. https:\/\/doi.org\/10.1186\/s12957-021-02234-1","journal-title":"World J Surg Oncol"},{"issue":"12","key":"10_CR29","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M (2022) Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell 82(12):2252\u20132266. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.027","journal-title":"Mol Cell"},{"issue":"2","key":"10_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00335-021-09901-4","volume":"33","author":"I Grammatikakis","year":"2022","unstructured":"Grammatikakis I, Lal A (2022) Significance of lncRNA abundance to function. Mamm Genome 33(2):271\u2013280. https:\/\/doi.org\/10.1007\/s00335-021-09901-4","journal-title":"Mamm Genome"},{"issue":"1","key":"10_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41418-022-01049-1","volume":"30","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Shao YJ, Hu WW, Zhang JP, Shi YF, Kong XY, Jiang JT (2022) A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3. Cell Death Differ 30(1):111\u2013124. https:\/\/doi.org\/10.1038\/s41418-022-01049-1","journal-title":"Cell Death Differ"},{"key":"10_CR32","doi-asserted-by":"publisher","unstructured":"Lee J, Kim DY, Kim Y, Shin US, Kim KS, Kim EJ (2023) IGFL2-AS1, a long non-coding RNA, is associated with radioresistance in colorectal cancer. Int J Mol Sci 24(2). https:\/\/doi.org\/10.3390\/ijms24020978","DOI":"10.3390\/ijms24020978"},{"issue":"7","key":"10_CR33","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/iub.2263","volume":"72","author":"F Liu","year":"2020","unstructured":"Liu F, Huang W, Hong J, Cai C, Zhang W, Zhang J, Kang Z (2020) Long noncoding RNA LINC00630 promotes radio-resistance by regulating BEX1 gene methylation in colorectal cancer cells. IUBMB Life 72(7):1404\u20131414. https:\/\/doi.org\/10.1002\/iub.2263","journal-title":"IUBMB Life"},{"issue":"11","key":"10_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152622","volume":"215","author":"Z Kang","year":"2019","unstructured":"Kang Z, Jifu E, Guo K, Ma X, Zhang Y, Yu E (2019) Knockdown of long non-coding RNA TINCR decreases radioresistance in colorectal cancer cells. Pathol Res Pract 215(11):152622. https:\/\/doi.org\/10.1016\/j.prp.2019.152622","journal-title":"Pathol Res Pract"},{"issue":"18","key":"10_CR35","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/emboj.2010.199","volume":"29","author":"D Bernard","year":"2010","unstructured":"Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan ZY, Zhang MQ, Sedel F, Jourdren L, Coulpier F, Triller A, Spector DL, Bessis A (2010) A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J 29(18):3082\u20133093. https:\/\/doi.org\/10.1038\/emboj.2010.199","journal-title":"EMBO J"},{"issue":"12","key":"10_CR36","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1097\/JTO.0b013e3182307eac","volume":"6","author":"LH Schmidt","year":"2011","unstructured":"Schmidt LH, Spieker T, Koschmieder S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D, Marra A, Hillejan L, Wiebe K, Berdel WE, Wiewrodt R, Muller-Tidow C (2011) The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 6(12):1984\u20131992. https:\/\/doi.org\/10.1097\/JTO.0b013e3182307eac","journal-title":"J Thorac Oncol"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.2147\/IJGM.S393270","volume":"15","author":"W Shen","year":"2022","unstructured":"Shen W, Yu Q, Pu Y, Xing C (2022) Upregulation of long noncoding RNA MALAT1 in colorectal cancer promotes Radioresistance and aggressive malignance. Int J Gener Med 15:8365\u20138380. https:\/\/doi.org\/10.2147\/IJGM.S393270","journal-title":"Int J Gener Med"},{"issue":"1","key":"10_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10238-024-01491-0","volume":"24","author":"AA Bhat","year":"2024","unstructured":"Bhat AA, Afzal M, Moglad E, Thapa R, Ali H, Almalki WH, Kazmi I, Alzarea SI, Gupta G, Subramaniyan V (2024) lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer. Clin Exp Med 24(1):226. https:\/\/doi.org\/10.1007\/s10238-024-01491-0","journal-title":"Clin Exp Med"},{"issue":"10","key":"10_CR39","doi-asserted-by":"publisher","first-page":"16971","DOI":"10.1002\/jcp.28417","volume":"234","author":"M Sarfi","year":"2019","unstructured":"Sarfi M, Abbastabar M, Khalili E (2019) Long noncoding RNAs biomarker-based cancer assessment. J Cell Physiol 234(10):16971\u201316986. https:\/\/doi.org\/10.1002\/jcp.28417","journal-title":"J Cell Physiol"},{"issue":"10","key":"10_CR40","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1158\/0008-5472.CAN-19-2687","volume":"80","author":"DZ Lv","year":"2020","unstructured":"Lv DZ, Xu K, Jin XY, Li JY, Shi YC, Zhang MY, Jin XY, Li YS, Xu J, Li X (2020) LncSpA: LncRNA spatial atlas of expression across nrmal and cancer tissues. Cancer Res 80(10):2067\u20132071. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2687","journal-title":"Cancer Res"},{"issue":"1","key":"10_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbagrm.2015.08.005","volume":"1859","author":"BS Gloss","year":"2016","unstructured":"Gloss BS, Dinger ME (2016) the specificity of long noncoding RNA expression. Bba-Gene Regul Mech 1859(1):16\u201322. https:\/\/doi.org\/10.1016\/j.bbagrm.2015.08.005","journal-title":"Bba-Gene Regul Mech"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3389\/Fimmu.2018.01739","volume":"9","author":"YY Yan","year":"2018","unstructured":"Yan YY, Kumar AB, Finnes H, Markovic SN, Park S, Dronca RS, Dong HD (2018) Combining immune checkpoint inhibitors with conventional cancer therapy. Front Immunol 9:1739. https:\/\/doi.org\/10.3389\/Fimmu.2018.01739","journal-title":"Front Immunol"},{"issue":"1","key":"10_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41420-021-00678-8","volume":"7","author":"SS Zhao","year":"2021","unstructured":"Zhao SS, Zhang X, Chen S, Zhang S (2021) Long noncoding RNAs: fine-tuners hidden in the cancer signaling network. Cell Death Discov 7(1):283. https:\/\/doi.org\/10.1038\/s41420-021-00678-8","journal-title":"Cell Death Discov"},{"issue":"19","key":"10_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/Ijms251910803","volume":"25","author":"N Bakalenko","year":"2024","unstructured":"Bakalenko N, Kuznetsova E, Malashicheva A (2024) The complex interplay of TGF-\u03b2 and notch signaling in the pathogenesis of fibrosis. Int J Mol Sci 25(19):10803. https:\/\/doi.org\/10.3390\/Ijms251910803","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10_CR45","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst RJ, Hata A (2012) Targeting the TGF\u03b2 signalling pathway in disease. Nat Rev Drug Discov 11(10):790\u2013811. https:\/\/doi.org\/10.1038\/nrd3810","journal-title":"Nat Rev Drug Discov"},{"issue":"17","key":"10_CR46","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1158\/0008-5472.CAN-11-1194","volume":"71","author":"D Javelaud","year":"2011","unstructured":"Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, Mauviel A (2011) TGF-\u03b2\/SMAD\/GLI2 signaling axis in cancer progression and metastasis. Cancer Res 71(17):5606\u20135610. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1194","journal-title":"Cancer Res"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1038\/onc.2013.322","volume":"32","author":"J Johansson","year":"2013","unstructured":"Johansson J, Berg T, Kurzejamska E, Pang MF, Fuxe J (2013) MiR-155-mediated loss of C\/EBP\u03b2 shifts the TGF-\u03b2 response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene 32:5614","journal-title":"Oncogene"},{"issue":"4","key":"10_CR48","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1053\/j.gastro.2011.07.048","volume":"141","author":"BR Achyut","year":"2011","unstructured":"Achyut BR, Yang L (2011) Transforming growth factor-\u03b2 in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology 141(4):1167\u20131178. https:\/\/doi.org\/10.1053\/j.gastro.2011.07.048","journal-title":"Gastroenterology"},{"key":"10_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155709","volume":"148","author":"J Wang","year":"2021","unstructured":"Wang J, Xu Z, Wang Z, Du G, Lun L (2021) TGF-beta signaling in cancer radiotherapy. Cytokine 148:155709. https:\/\/doi.org\/10.1016\/j.cyto.2021.155709","journal-title":"Cytokine"},{"key":"10_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104745","volume":"155","author":"B Farhood","year":"2020","unstructured":"Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Eleojo Musa A, Najafi M (2020) TGF-beta in radiotherapy: mechanisms of tumor resistance and normal tissues injury. Pharmacol Res 155:104745. https:\/\/doi.org\/10.1016\/j.phrs.2020.104745","journal-title":"Pharmacol Res"},{"key":"10_CR51","doi-asserted-by":"publisher","unstructured":"Wang L, Lynch C, Pitroda SP, Piffko A, Yang K, Huser AK, Liang HL, Weichselbaum RR (2024) Radiotherapy and immunology. J Exp Med 221(7). https:\/\/doi.org\/10.1084\/jem.20232101","DOI":"10.1084\/jem.20232101"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biopha.2018.12.055","volume":"111","author":"P Yadav","year":"2019","unstructured":"Yadav P, Shankar BS (2019) Radio resistance in breast cancer cells is mediated through TGF-\u03b2 signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells. Biomed Pharmacother 111:119\u2013130","journal-title":"Biomed Pharmacother"},{"key":"10_CR53","doi-asserted-by":"publisher","unstructured":"Lee H, Kong JS, Lee SS, Kim A (2021) Radiation-induced overexpression of TGFbeta and PODXL contributes to colorectal cancer cell Radioresistance through enhanced motility. Cells-Basel 10(8). https:\/\/doi.org\/10.3390\/cells10082087","DOI":"10.3390\/cells10082087"},{"issue":"8","key":"10_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41419-023-06060-z","volume":"14","author":"YL Zhang","year":"2023","unstructured":"Zhang YL, Lv N, Li MS, Liu M, Wu CL (2023) Cancer-associated fibroblasts: tumor defenders in radiation therapy. Cell Death Dis 14(8):541. https:\/\/doi.org\/10.1038\/s41419-023-06060-z","journal-title":"Cell Death Dis"},{"issue":"1","key":"10_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-019-1507-2","volume":"39","author":"X Chen","year":"2020","unstructured":"Chen X, Liu J, Zhang Q, Liu B, Cheng Y, Zhang Y, Sun Y, Ge H, Liu Y (2020) Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3. J Exper Clin Cancer Res 39(1):65. https:\/\/doi.org\/10.1186\/s13046-019-1507-2","journal-title":"J Exper Clin Cancer Res"},{"issue":"2","key":"10_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111956","volume":"391","author":"L Liu","year":"2020","unstructured":"Liu L, Zhang Z, Zhou L, Hu L, Yin C, Qing D, Huang S, Cai X, Chen Y (2020) Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype. Exp Cell Res 391(2):111956. https:\/\/doi.org\/10.1016\/j.yexcr.2020.111956","journal-title":"Exp Cell Res"},{"issue":"7092","key":"10_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M (2006) Nuclear factor-\u03baB in cancer development and progression. Nature 441(7092):431\u2013436. https:\/\/doi.org\/10.1038\/nature04870","journal-title":"Nature"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","volume":"246","author":"SC Sun","year":"2012","unstructured":"Sun SC (2012) The noncanonical NF-\u03baB pathway. Immunol Rev 246:125\u2013140. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01088.x","journal-title":"Immunol Rev"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","volume":"27","author":"S Vallabhapurapu","year":"2009","unstructured":"Vallabhapurapu S, Karin M (2009) Regulation and function of NF-\u03baB transcription factors in the immune system. Annu Rev Immunol 27:693\u2013733. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132641","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10_CR60","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/1750-3841.15156","volume":"85","author":"WL Huang","year":"2020","unstructured":"Huang WL, Wu SF, Xu ST, Ma YC, Wang R, Jin SJ, Zhou S (2020) Allicin enhances the radiosensitivity of colorectal cancer cells via inhibition of NF-\u03baB signaling pathway. J Food Sci 85(6):1924\u20131931. https:\/\/doi.org\/10.1111\/1750-3841.15156","journal-title":"J Food Sci"},{"issue":"4","key":"10_CR61","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41416-022-01835-1","volume":"127","author":"L Yu","year":"2022","unstructured":"Yu L, Guo Q, Luo Z, Wang Y, Weng J, Chen Y, Liang W, Li Y, Zhang Y, Chen K, Chen Z, Ding Y, Zhang Y (2022) TXN inhibitor impedes radioresistance of colorectal cancer cells with decreased ALDH1L2 expression via TXN\/NF-kappaB signaling pathway. Br J Cancer 127(4):637\u2013648. https:\/\/doi.org\/10.1038\/s41416-022-01835-1","journal-title":"Br J Cancer"},{"key":"10_CR62","doi-asserted-by":"publisher","unstructured":"Lee SC, Shen CY, Wang WH, Lee YP, Liang KW, Chou YH, Tyan YS, Hwang JJ (2023) Synergistic effect of ginsenoside Rh2 combines with ionizing radiation on CT26\/luc colon carcinoma cells and tumor-bearing animal model. Pharmaceuticals 16(9). https:\/\/doi.org\/10.3390\/ph16091188","DOI":"10.3390\/ph16091188"},{"issue":"1","key":"10_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biopha.2011.09.011","volume":"66","author":"YC Kuo","year":"2012","unstructured":"Kuo YC, Lin WC, Chiang IT, Chang YF, Chen CW, Su SH, Chen CL, Hwang JJ (2012) Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-kappaB expression in vitro and in vivo. Biomed Pharmacother 66(1):12\u201320. https:\/\/doi.org\/10.1016\/j.biopha.2011.09.011","journal-title":"Biomed Pharmacother"},{"key":"10_CR64","doi-asserted-by":"publisher","unstructured":"Hou Y, Liang H, Rao E, Zheng W, Huang X, Deng L, Zhang Y, Yu X, Xu M, Mauceri H, Arina A, Weichselbaum RR, Fu YX (2018) Non-canonical NF-kappaB antagonizes STING sensor-mediated DNA sensing in radiotherapy. Immunity 49(3):490\u2013503 e494. https:\/\/doi.org\/10.1016\/j.immuni.2018.07.008","DOI":"10.1016\/j.immuni.2018.07.008"},{"issue":"7","key":"10_CR65","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","volume":"41","author":"L Wang","year":"2023","unstructured":"Wang L, Dou X, Chen S, Yu X, Huang X, Zhang L, Chen Y, Wang J, Yang K, Bugno J, Pitroda S, Ding X, Piffko A, Si W, Chen C, Jiang H, Zhou B, Chmura SJ, Luo C, Liang HL, He C, Weichselbaum RR (2023) YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell 41(7):1294\u20131308. e1298. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.019","journal-title":"Cancer Cell"},{"issue":"3","key":"10_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB (2022) The hallmarks of cancer metabolism: still emerging. Cell Metab 34(3):355\u2013377. https:\/\/doi.org\/10.1016\/j.cmet.2022.01.007","journal-title":"Cell Metab"},{"issue":"1","key":"10_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1566523222666220830150446","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Huang H, Wu S, Zhou Y, Huang T, Jiang J (2023) The role of RNA m(6)A modification in cancer glycolytic reprogramming. Curr Gene Ther 23(1):51\u201359. https:\/\/doi.org\/10.2174\/1566523222666220830150446","journal-title":"Curr Gene Ther"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27:441\u2013464. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154237","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2022.104600","volume":"262","author":"MZ Islam Khan","year":"2022","unstructured":"Islam Khan MZ, Tam SY, Azam Z, Law HKW (2022) Proteomic profiling of metabolic proteins as potential biomarkers of radioresponsiveness for colorectal cancer. J Proteome 262:104600. https:\/\/doi.org\/10.1016\/j.jprot.2022.104600","journal-title":"J Proteome"},{"issue":"8","key":"10_CR70","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520946169","volume":"48","author":"X Li","year":"2020","unstructured":"Li X, Tian R, Liu L, Wang L, He D, Cao K, Ma JK, Huang C (2020) Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells. J Int Med Res 48(8):300060520946169. https:\/\/doi.org\/10.1177\/0300060520946169","journal-title":"J Int Med Res"},{"issue":"9","key":"10_CR71","first-page":"4923","volume":"12","author":"RF Tian","year":"2020","unstructured":"Tian RF, Li XF, Xu C, Wu H, Liu L, Wang LH, He D, Cao K, Cao PG, Ma JK, Huang CH (2020) SiRNA targeting PFK1 inhibits proliferation and migration and enhances radiosensitivity by suppressing glycolysis in colorectal cancer. Am J Transl Res 12(9):4923\u20134940","journal-title":"Am J Transl Res"},{"issue":"9","key":"10_CR72","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41419-021-03984-2","volume":"12","author":"Y Shi","year":"2021","unstructured":"Shi Y, Wang Y, Jiang H, Sun X, Xu H, Wei X, Wei Y, Xiao G, Song Z, Zhou F (2021) Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca(2+)](m)-PDP1-PDH-histone acetylation retrograde signaling. Cell Death Dis 12(9):837. https:\/\/doi.org\/10.1038\/s41419-021-03984-2","journal-title":"Cell Death Dis"},{"issue":"12","key":"10_CR73","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.7150\/thno.33100","volume":"9","author":"C Sun","year":"2019","unstructured":"Sun C, Liu XX, Wang B, Wang ZH, Liu Y, Di CX, Si J, Li HY, Wu QF, Xu D, Li J, Li G, Wang YP, Wang F, Zhang H (2019) Endocytosis-mediated mitochondrial transplantation: transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity. Theranostics 9(12):3595\u20133607. https:\/\/doi.org\/10.7150\/thno.33100","journal-title":"Theranostics"},{"issue":"2","key":"10_CR74","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1667\/Rr15021.1","volume":"190","author":"YH Wei","year":"2018","unstructured":"Wei YH, Chen LL, Xu H, Xie CH, Zhou YF, Zhou FX (2018) Mitochondrial dysfunctions regulated Radioresistance through mitochondria-to-nucleus retrograde signaling pathway of NF-\u03baB\/PI3K\/AKT2\/mTOR. Radiat Res 190(2):204\u2013215. https:\/\/doi.org\/10.1667\/Rr15021.1","journal-title":"Radiat Res"},{"key":"10_CR75","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.biopha.2018.04.099","volume":"103","author":"JJ Mou","year":"2018","unstructured":"Mou JJ, Peng J, Shi YY, Li N, Wang Y, Ke Y, Zhou YF, Zhou FX (2018) Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells. Biomed Pharmacother 103:729\u2013737. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.099","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10_CR76","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6(1):162. https:\/\/doi.org\/10.1038\/s41392-021-00553-z","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10_CR77","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41419-022-04526-0","volume":"13","author":"M Zanoni","year":"2022","unstructured":"Zanoni M, Sarti AC, Zamagni A, Cortesi M, Pignatta S, Arienti C, Tebaldi M, Sarnelli A, Romeo A, Bartolini D, Tosatto L, Adinolfi E, Tesei A, Di Virgilio F (2022) Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma. Cell Death Dis 13(1):80. https:\/\/doi.org\/10.1038\/s41419-022-04526-0","journal-title":"Cell Death Dis"},{"issue":"1","key":"10_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1269\/Jrr.45.33","volume":"45","author":"S Kojima","year":"2004","unstructured":"Kojima S, Nakayama K, Ishida H (2004) Low dose \u03b3-rays activate immune functions via induction of glutathione and delay tumor growth. J Radiat Res 45(1):33\u201339. https:\/\/doi.org\/10.1269\/Jrr.45.33","journal-title":"J Radiat Res"},{"issue":"1","key":"10_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2131\/jts.39.15","volume":"39","author":"S Ide","year":"2014","unstructured":"Ide S, Nishimaki N, Tsukimoto M, Kojima S (2014) Purine receptor P2Y6 mediates cellular response to \u03b3-ray-induced DNA damage. J Toxicol Sci 39(1):15\u201323","journal-title":"J Toxicol Sci"},{"key":"10_CR80","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.dnarep.2012.05.005","volume":"11","author":"N Nishimaki","year":"2012","unstructured":"Nishimaki N, Tsukimoto M, Kitami A, Kojima S (2012) Autocrine regulation of \u03b3-irradiation-induced DNA damage response via extracellular nucleotides-mediated activation of P2Y6 and P2Y12 receptors. DNA Repair 11:657","journal-title":"DNA Repair"},{"issue":"1","key":"10_CR81","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41419-023-06408-5","volume":"15","author":"KC Huang","year":"2024","unstructured":"Huang KC, Chiang SF, Lin PC, Hong WZ, Yang PC, Chang HP, Peng SL, Chen TW, Ke TW, Liang JA, Chen WT, Chao KSC (2024) TNFalpha modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell Death Dis 15(1):24. https:\/\/doi.org\/10.1038\/s41419-023-06408-5","journal-title":"Cell Death Dis"},{"issue":"25","key":"10_CR82","doi-asserted-by":"publisher","first-page":"20840","DOI":"10.18632\/oncotarget.4428","volume":"6","author":"E Vacchelli","year":"2015","unstructured":"Vacchelli E, Semeraro M, Enot DP, Chaba K, Kroemer G (2015) Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. Oncotarget 6(25):20840\u201320850","journal-title":"Oncotarget"},{"key":"10_CR83","doi-asserted-by":"crossref","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Publ Group (2)","DOI":"10.1038\/s41573-018-0004-1"},{"issue":"3","key":"10_CR84","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1158\/0008-5472.CAN-17-0524","volume":"78","author":"J Tommelein","year":"2018","unstructured":"Tommelein J, De Vlieghere E, Verset L, Melsens E, Leenders J, Descamps B, Debucquoy A, Vanhove C, Pauwels P, Gespach CP, Vral A, De Boeck A, Haustermans K, de Tullio P, Ceelen W, Demetter P, Boterberg T, Bracke M, De Wever O (2018) Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation. Cancer Res 78(3):659\u2013670. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0524","journal-title":"Cancer Res"},{"key":"10_CR85","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.omtn.2020.11.003","volume":"24","author":"XJ Chen","year":"2021","unstructured":"Chen XJ, Liu YQ, Zhang QL, Liu BX, Cheng Y, Zhang YL, Sun YN, Liu JQ (2021) Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer. Mol Ther Nucl Acids 24:113\u2013126. https:\/\/doi.org\/10.1016\/j.omtn.2020.11.003","journal-title":"Mol Ther Nucl Acids"},{"key":"10_CR86","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2023.09.065","volume":"681","author":"L Yan","year":"2023","unstructured":"Yan L, Zheng J, Wang Q, Hao H (2023) Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targets. Biochem Biophys Res Commun 681:127\u2013135. https:\/\/doi.org\/10.1016\/j.bbrc.2023.09.065","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10_CR87","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3892\/ijo.2011.906","volume":"38","author":"S Saigusa","year":"2011","unstructured":"Saigusa S, Toiyama Y, Tanaka K, Yokoe T, Okugawa Y, Fujikawa H, Matsusita K, Kawamura M, Inoue Y, Miki C, Kusunoki M (2011) Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int J Oncol 38(3):655\u2013663. https:\/\/doi.org\/10.3892\/ijo.2011.906","journal-title":"Int J Oncol"},{"issue":"1","key":"10_CR88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3892\/or.2013.2860","volume":"31","author":"VS Schellerer","year":"2014","unstructured":"Schellerer VS, Langheinrich M, Hohenberger W, Croner RS, Merkel S, Rau TT, Sturzl M, Naschberger E (2014) Tumor-associated fibroblasts isolated from colorectal cancer tissues exhibit increased ICAM-1 expression and affinity for monocytes. Oncol Rep 31(1):255\u2013261. https:\/\/doi.org\/10.3892\/or.2013.2860","journal-title":"Oncol Rep"},{"key":"10_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106298","volume":"81","author":"M Wang","year":"2020","unstructured":"Wang M, Su Z, Barnie PA (2020) Crosstalk among colon cancer-derived exosomes, fibroblast-derived exosomes, and macrophage phenotypes in colon cancer metastasis. Int Immunopharmacol 81:106298","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10_CR90","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1440167","volume":"7","author":"J Jacobs","year":"2018","unstructured":"Jacobs J, Deschoolmeester V, Zwaenepoel K, Flieswasser T, Deben C, Van den Bossche J, Hermans C, Rolfo C, Peeters M, De Wever O, Lardon F, Siozopoulou V, Smits E, Pauwels P (2018) Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation. Onco Targets Ther 7(7):e1440167. https:\/\/doi.org\/10.1080\/2162402X.2018.1440167","journal-title":"Onco Targets Ther"},{"issue":"11","key":"10_CR91","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/jcp.25016","volume":"230","author":"D Wolf","year":"2015","unstructured":"Wolf D, Sopper S, Pircher A, Gastl G, Wolf AM (2015) Treg(s) in cancer: friends or foe? J Cell Physiol 230(11):2598\u20132605. https:\/\/doi.org\/10.1002\/jcp.25016","journal-title":"J Cell Physiol"},{"issue":"7","key":"10_CR92","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10(7):490\u2013500. https:\/\/doi.org\/10.1038\/nri2785","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10_CR93","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H (2019) Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol 16(6):356\u2013371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10_CR94","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing JB, Tanaka A, Sakaguchi S (2019) Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50(2):302\u2013316. https:\/\/doi.org\/10.1016\/j.immuni.2019.01.020","journal-title":"Immunity"},{"issue":"10","key":"10_CR95","doi-asserted-by":"publisher","first-page":"8261","DOI":"10.18632\/oncotarget.3014","volume":"6","author":"M Napolitano","year":"2015","unstructured":"Napolitano M, D\u2019Alterio C, Cardone E, Trotta AM, Pecori B, Rega D, Pace U, Scala D, Scognamiglio G, Tatangelo F, Cacciapuoti C, Pacelli R, Delrio P, Scala S (2015) Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients. Oncotarget 6(10):8261\u20138270. https:\/\/doi.org\/10.18632\/oncotarget.3014","journal-title":"Oncotarget"},{"key":"10_CR96","doi-asserted-by":"crossref","unstructured":"Schmidt MA, F\u00f6rtsch C, Schmidt M, Rau TT, Fietkau R, Distel LV (2012) Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment. Radiother Oncol 104(1):131\u2013138","DOI":"10.1016\/j.radonc.2012.05.003"},{"issue":"1","key":"10_CR97","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3322\/caac.21358","volume":"67","author":"FG Herrera","year":"2017","unstructured":"Herrera FG, Bourhis J, Coukos G (2017) Radiotherapy combination opportunities leveraging immunity for the next oncology practice. CA Cancer J Clin 67(1):65\u201385. https:\/\/doi.org\/10.3322\/caac.21358","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10_CR98","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2015.03.003","volume":"368","author":"E Persa","year":"2015","unstructured":"Persa E, Balogh A, Safrany G, Lumniczky K (2015) The effect of ionizing radiation on regulatory T cells in health and disease. Cancer Lett 368(2):252\u2013261. https:\/\/doi.org\/10.1016\/j.canlet.2015.03.003","journal-title":"Cancer Lett"},{"key":"10_CR99","doi-asserted-by":"publisher","unstructured":"Turnis ME, Sawant DV, Szymczak-Workman AL, Andrews LP, Delgoffe GM, Yano H, Beres AJ, Vogel P, Workman CJ, Vignali DA (2016) Interleukin-35 limits anti-tumor immunity. Immunity 44(2):316\u2013329. https:\/\/doi.org\/10.1016\/j.immuni.2016.01.013","DOI":"10.1016\/j.immuni.2016.01.013"},{"issue":"11","key":"10_CR100","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1158\/2326-6066.CIR-17-0040","volume":"5","author":"Y Muroyama","year":"2017","unstructured":"Muroyama Y, Nirschl TR, Kochel CM, Lopez-Bujanda Z, Theodros D, Mao W, Carrera-Haro MA, Ghasemzadeh A, Marciscano AE, Velarde E, Tam AJ, Thoburn CJ, Uddin M, Meeker AK, Anders RA, Pardoll DM, Drake CG (2017) Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment. Cancer Immunol Res 5(11):992\u20131004. https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0040","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"10_CR101","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ijc.31744","volume":"144","author":"Z Yin","year":"2019","unstructured":"Yin Z, Li C, Wang J, Xue L (2019) Myeloid-derived suppressor cells: roles in the tumor microenvironment and tumor radiotherapy. Int J Cancer 144(5):933\u2013946. https:\/\/doi.org\/10.1002\/ijc.31744","journal-title":"Int J Cancer"},{"issue":"2","key":"10_CR102","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1004983","volume":"5","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Wu T, Shao S, Shi B, Zhao Y (2016) Phenotype, development, and biological function of myeloid-derived suppressor cells. Onco Targets Ther 5(2):e1004983. https:\/\/doi.org\/10.1080\/2162402X.2015.1004983","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10_CR103","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/08923973.2015.1059442","volume":"37","author":"Y Liu","year":"2015","unstructured":"Liu Y, Wei J, Guo G, Zhou J (2015) Norepinephrine-induced myeloid-derived suppressor cells block T-cell responses via generation of reactive oxygen species. Immunopharmacol Immunotoxicol 37(4):359\u2013365. https:\/\/doi.org\/10.3109\/08923973.2015.1059442","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10_CR104","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.critrevonc.2017.01.017","volume":"111","author":"E Chajon","year":"2017","unstructured":"Chajon E, Castelli J, Marsiglia H, De Crevoisier R (2017) The synergistic effect of radiotherapy and immunotherapy: a promising but not simple partnership. Crit Rev Oncol Hematol 111:124\u2013132. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.01.017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10_CR105","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.medj.2023.09.001","volume":"4","author":"L Wang","year":"2023","unstructured":"Wang L, Katipally RR, Liang HL, Yang K, Pitroda SP, He C, Weichselbaum RR (2023) RNA m(6)A methylation and MDSCs: roles and therapeutic implications for radiotherapy. Med 4(12):863\u2013874. https:\/\/doi.org\/10.1016\/j.medj.2023.09.001","journal-title":"Med"},{"issue":"1","key":"10_CR106","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s41467-017-01566-5","volume":"8","author":"H Liang","year":"2017","unstructured":"Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E, Zheng W, Mauceri H, Mack M, Xu M, Fu YX, Weichselbaum RR (2017) Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun 8(1):1736. https:\/\/doi.org\/10.1038\/s41467-017-01566-5","journal-title":"Nat Commun"},{"issue":"2","key":"10_CR107","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.radonc.2016.01.014","volume":"119","author":"W Leonard","year":"2016","unstructured":"Leonard W, Dufait I, Schwarze JK, Law K, Engels B, Jiang H, Van den Berge D, Gevaert T, Storme G, Verovski V, Breckpot K, De Ridder M (2016) Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion. Radiother Oncol 119(2):291\u2013299. https:\/\/doi.org\/10.1016\/j.radonc.2016.01.014","journal-title":"Radiother Oncol"},{"issue":"7","key":"10_CR108","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/j.1349-7006.2011.01940.x","volume":"102","author":"K Yasuda","year":"2011","unstructured":"Yasuda K, Nirei T, Tsuno NH, Nagawa H, Kitayama J (2011) Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer. Cancer Sci 102(7):1257\u20131263. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01940.x","journal-title":"Cancer Sci"},{"issue":"9","key":"10_CR109","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-23-3206","volume":"30","author":"Y Hou","year":"2024","unstructured":"Hou Y, Yang K, Wang L, Wang J, Huang X, Piffko A, Luo SZ, Yu X, Rao E, Martinez C, Bugno J, Mack M, Vokes EE, Pitroda SP, Chmura SJ, Weichselbaum RR, Liang HL (2024) Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites. Clin Cancer Res 30(9):1945\u20131958. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-3206","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10_CR110","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","volume":"18","author":"A Sica","year":"2008","unstructured":"Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A (2008) Macrophage polarization in tumour progression. Semin Cancer Biol 18(5):349\u2013355. https:\/\/doi.org\/10.1016\/j.semcancer.2008.03.004","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"10_CR111","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958\u2013969. https:\/\/doi.org\/10.1038\/nri2448","journal-title":"Nat Rev Immunol"},{"issue":"42","key":"10_CR112","doi-asserted-by":"publisher","first-page":"72597","DOI":"10.18632\/oncotarget.19994","volume":"8","author":"MM Leblond","year":"2017","unstructured":"Leblond MM, P\u00e9r\u00e8s EA, Helaine C, G\u00e9rault AN, Valable MBS (2017) M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma. Oncotarget 8(42):72597\u201372612","journal-title":"Oncotarget"},{"issue":"7","key":"10_CR113","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma RY, Black A, Qian BZ (2022) Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol 43(7):546\u2013563. https:\/\/doi.org\/10.1016\/j.it.2022.04.008","journal-title":"Trends Immunol"},{"issue":"1","key":"10_CR114","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1038\/s41467-021-23442-z","volume":"12","author":"Z Bian","year":"2021","unstructured":"Bian Z, Shi L, Kidder K, Zen K, Garnett-Benson C, Liu Y (2021) Intratumoral SIRPalpha-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy. Nat Commun 12(1):3229. https:\/\/doi.org\/10.1038\/s41467-021-23442-z","journal-title":"Nat Commun"},{"issue":"3","key":"10_CR115","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.3892\/mmr.2016.4820","volume":"13","author":"LN Shao","year":"2016","unstructured":"Shao LN, Zhu BS, Xing CG, Yang XD, Young W, Cao JP (2016) Effects of autophagy regulation of tumor-associated macrophages on radiosensitivity of colorectal cancer cells. Mol Med Rep 13(3):2661\u20132670. https:\/\/doi.org\/10.3892\/mmr.2016.4820","journal-title":"Mol Med Rep"},{"issue":"2","key":"10_CR116","doi-asserted-by":"publisher","first-page":"695","DOI":"10.4103\/jcrt.jcrt_215_23","volume":"20","author":"L Shao","year":"2024","unstructured":"Shao L, Wu Y, Cao J, Zhong F, Yang X, Xing C (2024) Activation of M2 macrophage autophagy by rapamycin increases the radiosensitivity of colorectal cancer xenografts. J Cancer Res Ther 20(2):695\u2013705. https:\/\/doi.org\/10.4103\/jcrt.jcrt_215_23","journal-title":"J Cancer Res Ther"},{"key":"10_CR117","doi-asserted-by":"publisher","unstructured":"Stary V, Wolf B, Unterleuthner D, List J, Talic M, Laengle J, Beer A, Strobl J, Stary G, Dolznig H, Bergmann M (2020) Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer. J Immunother Cancer 8(2). https:\/\/doi.org\/10.1136\/jitc-2020-000667","DOI":"10.1136\/jitc-2020-000667"}],"container-title":["Methods in Molecular Biology","Microbial \u2018Omics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5264-0_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:40:15Z","timestamp":1778456415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5264-0_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652633","9781071652640"],"references-count":117,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5264-0_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}